Your browser doesn't support javascript.
loading
Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial.
Natukunda, Eva; Gaur, Aditya H; Kosalaraksa, Pope; Batra, Jagmohan; Rakhmanina, Natella; Porter, Danielle; Shao, Yongwu; Zhang, Heather; Pikora, Cheryl; Rhee, Martin S.
Afiliación
  • Natukunda E; Joint Clinical Research Centre, Kampala, Uganda.
  • Gaur AH; St Jude Children's Research Hospital, Memphis, TN, USA.
  • Kosalaraksa P; Khon Kaen University, Khon Kaen, Thailand.
  • Batra J; Miller Children's Hospital, Long Beach, CA, USA.
  • Rakhmanina N; Children's Research Institute-Children's National Medical Center, Washington, DC, USA.
  • Porter D; Gilead Sciences, Foster City, CA, USA.
  • Shao Y; Gilead Sciences, Foster City, CA, USA.
  • Zhang H; Gilead Sciences, Foster City, CA, USA.
  • Pikora C; Gilead Sciences, Foster City, CA, USA.
  • Rhee MS; Gilead Sciences, Foster City, CA, USA. Electronic address: martin.rhee@gilead.com.
Lancet Child Adolesc Health ; 1(1): 27-34, 2017 Sep.
Article en En | MEDLINE | ID: mdl-30169223

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Lancet Child Adolesc Health Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Lancet Child Adolesc Health Año: 2017 Tipo del documento: Article